Cargando…

Aflibercept as a Treatment for Secondary Central Serous Chorioretinopathy in a Patient With Myasthenia Gravis

We report on a case of central serous chorioretinopathy (CSCR) secondary to chronic steroid use that showed sustained improvement when treated with an aflibercept intravitreal injection. A 44-year-old woman presented with decreased visual acuity of the left eye (OS). The patient had a recent history...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramirez Marquez, Estefania, Requejo Figueroa, Guillermo A, Pappaterra-Rodriguez, Mariella, Ayala Rodríguez, Sofía C, Puebla, Guillermo, Nieves, Ileana, Oliver, Armando L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Ophthalmology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733583/ https://www.ncbi.nlm.nih.gov/pubmed/36514621 http://dx.doi.org/10.7759/cureus.31287

Ejemplares similares

Unilateral Focal Retinitis as an Initial Manifestation of Cat-Scratch Disease
por: Santos, David F, et al.
Publicado: (2022)

Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023)

Contralateral Recurrences of Post-vaccination Multiple Evanescent White Dot Syndrome
por: Ramirez Marquez, Estefania, et al.
Publicado: (2022)

Pars Plana Vitrectomy With Internal Limiting Membrane Peeling for the Treatment of Cystoid Macular Edema in a Patient With Syphilitic Uveitis and HIV Infection
por: Pappaterra-Rodriguez, Mariella C, et al.
Publicado: (2022)

Aflibercept for the Treatment of Macular Edema Secondary to Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome
por: López Fontanet, José, et al.
Publicado: (2023)

Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China
por: Zhao, Tantai, et al.
Publicado: (2023)

Interobserver Agreement of Novel Classification of Central Serous Chorioretinopathy
por: Sahoo, Niroj K, et al.
Publicado: (2022)

Bilateral Acute Iris Transillumination Syndrome Following Oral Moxifloxacin Overdose
por: Mendez Bermudez, Israel J, et al.
Publicado: (2023)

Central serous chorioretinopathy in primary hyperaldosteronism
por: van Dijk, Elon H. C., et al.
Publicado: (2016)

Bilateral Central Serous Chorioretinopathy After Treatment of COVID-19 Infection
por: Sharifi, Ali, et al.
Publicado: (2022)

Multifocal Central Serous Chorioretinopathy Associated with Steroids in a Patient with Myasthenia Gravis
por: Stefaniotou, Maria, et al.
Publicado: (2013)

Variables in the ACBD5 Gene Leading to Distinct Phenotypes: A Case Report
por: Pappaterra-Rodriguez, Mariella C, et al.
Publicado: (2022)

Retinal Imaging and Optical Coherence Tomography of Choroidal Haemangioma Mimicking Central Serous Chorioretinopathy
por: Jugnarain, Davina, et al.
Publicado: (2023)

Systemic Disease Associations in a Cohort of Hispanic Patients with Scleritis
por: Arruza, Cristina, et al.
Publicado: (2023)

Clinical characteristics of ocular myasthenia gravis and outcomes of secondary generalisation: a systematic review protocol
por: Fang, Clarissa E H, et al.
Publicado: (2022)

Bilateral and Multiple Central Serous Chorioretinopathy Following COVID-19 Infection: A Case Report and Literature Review
por: Mohd-Alif, W Mohd, et al.
Publicado: (2022)

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea
por: van Dijk, Elon H. C., et al.
Publicado: (2017)

The Uses of Photodynamic Therapy Versus Anti-vascular Endothelial Growth Factor in the Management of Acute Central Serous Chorioretinopathy: A Systematic Review and Meta-Analysis
por: Seraj, Hadeel, et al.
Publicado: (2023)

Clinical Signs in Neuro-Ophthalmology: Eye Signs in Myasthenia Gravis
por: Wong, Sui Hsien
Publicado: (2022)

Optical coherence tomography angiography of central serous chorioretinopathy: quantitative evaluation of the vascular pattern and capillary flow density
por: Roberta, Farci, et al.
Publicado: (2021)

Multicentre, randomised clinical trial comparing intravitreal aflibercept monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) for the treatment of polypoidal choroidal vasculopathy
por: Vyas, Chinmayi Himanshuroy, et al.
Publicado: (2021)

Bilateral Lupus Chorioretinopathy in a Patient With Active Systemic Lupus Erythematosus
por: David, Sharoon, et al.
Publicado: (2022)

Submacular Hemorrhage Following Aflibercept Intravitreal Injection: A Report of Two Cases
por: Khoo, Chloe, et al.
Publicado: (2022)

West Indian (Caribbean) Punctate Keratopathy in a Puerto Rican Girl
por: Ramirez Marquez, Estefania, et al.
Publicado: (2023)

Protocol for a randomised, double-masked, sham-controlled phase 4 study on the efficacy, safety and tolerability of intravitreal aflibercept monotherapy compared with aflibercept with adjunctive photodynamic therapy in polypoidal choroidal vasculopathy: the ATLANTIC study
por: Marques, João Pedro, et al.
Publicado: (2017)

Consequences of Purtscher-Like Retinopathy in a Patient With Systemic Lupus Erythematosus: A Case Report
por: Ramirez Marquez, Estefania, et al.
Publicado: (2023)

Managing a Pigmented Corneal Ulcer in a 58-Year-Old Patient
por: Acosta, Alejandro, et al.
Publicado: (2023)

Evaluation of the Retinal Vessel Density and Subfoveal Choroidal Thickness in Central Cerous Chorioretinopathy Using Optical Coherence Tomography
por: Doan, Thanh K, et al.
Publicado: (2023)

Intravitreal Ziv-Aflibercept in Treatment of Naïve Chronic Central Serous Chorioretinopathy Related Choroidal Neovascular Membrane
por: Radke, Nishant, et al.
Publicado: (2017)

Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy
por: Yamada, Chizu, et al.
Publicado: (2022)

An Uncommon Aflibercept Side Effect: Full Thickness Macular Hole Formation After Intravitreal Injections in Patients With Pre-existing Vitreomacular Traction
por: Karamitsos, Athanasios, et al.
Publicado: (2021)

Bilateral Acute Retinal Necrosis Treated With Antivirals and Corticosteroids
por: Ramirez Marquez, Estefania, et al.
Publicado: (2023)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Rapidly Changing Serous Detachment During BRAF and MEK Inhibitor Therapy
por: Agata, Chisato, et al.
Publicado: (2021)

Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial
por: Sivaprasad, Sobha, et al.
Publicado: (2015)

A Comparative Study of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration: 12-Month Outcomes of Polish Therapeutic Program in Non-Tertiary Institution
por: Skrzypczak, Tomasz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bfloi7t05chka4j8er43sluf5a